| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Fee income | ||||||||||
1,564 | 1,488 | - | - | - | - | - | - | - | - | - |
Fee income | ||||||||||
- | - | 1,509 | 1,236 | 2,007 | 1,598 | - | - | - | - | - |
Operating expenses | ||||||||||
3,677 | 3,043 | 3,127 | 4,086 | - | - | - | - | - | - | - |
Fee income | ||||||||||
- | - | - | - | - | - | 2,161 | 1,957 | 845 | 767 | 709 |
Operating expenses | ||||||||||
- | - | - | - | 4,742 | 4,425 | 6,036 | 4,101 | 3,618 | 3,253 | 3,183 |
Research and development | ||||||||||
1,035 | 863 | 799 | 1,417 | 1,588 | 1,621 | 2,203 | 1,671 | 1,390 | 1,404 | 1,549 |
Loss on impairment of fixed asset | ||||||||||
50 | - | - | - | - | - | - | - | - | - | - |
Total expenses | ||||||||||
4,764 | 3,906 | 3,927 | 5,504 | 6,330 | 6,047 | 8,240 | 5,773 | 5,009 | 4,657 | 4,733 |
Operating loss | ||||||||||
-3,200 | -2,418 | -2,418 | -4,267 | -4,323 | -4,448 | -6,078 | -3,816 | -4,163 | -3,890 | -4,023 |
Warrant market adjustment | ||||||||||
652 | 278 | - | - | - | - | - | - | - | - | - |
Net investment income | ||||||||||
43 | 10 | 4 | 29 | 43 | 35 | 38 | 33 | 29 | 15 | 20 |
Loss before income tax benefit | ||||||||||
- | - | - | - | - | - | - | -3,782 | -4,134 | -3,874 | - |
Income tax benefit | ||||||||||
- | - | - | - | - | - | - | -613 | 0 | 0 | - |
Net loss | ||||||||||
-3,808 | -2,686 | -2,413 | -4,238 | -4,279 | -4,413 | -6,040 | -3,169 | -4,134 | -3,874 | -4,002 |
Basic and diluted net loss per common share | ||||||||||
-0.13 | -0.10 | -0.10 | -0.18 | -0.18 | -0.19 | -0.26 | -0.16 | -0.22 | -0.22 | -0.25 |
Weighted average number of common shares outstanding | ||||||||||
30,011 | 25,956 | 24,043 | 24,043 | 24,007 | 23,663 | 22,946 | 20,125 | 18,538 | - | - |
Basic and diluted weighted average number of common shares outstanding (in shares) | ||||||||||
- | - | - | - | - | - | - | - | - | 17,321 | 16,065 |